<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; ESRX</title>
	<atom:link href="http://www.stockbloghub.com/tag/esrx/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(ABC) AmerisourceBergen Posts Modest Second Quarter Results</title>
		<link>http://www.stockbloghub.com/2012/04/30/abc-amerisourcebergen-posts-modest-second-quarter-results/99760</link>
		<comments>http://www.stockbloghub.com/2012/04/30/abc-amerisourcebergen-posts-modest-second-quarter-results/99760#comments</comments>
		<pubDate>Mon, 30 Apr 2012 18:00:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs Wholesale]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=99760</guid>
		<description><![CDATA[AmerisourceBergen Corporation (ABC) posted second quarter fiscal 2012 earnings of 81 cents per share, in line with the Zacks Consensus Estimate. However, earnings increased 5.2% from the year-ago period, spurred by higher revenues and a lower share count. Revenues Total revenue for the second quarter edged up 1.6% to $20.1 billion, which were also in line with the Zacks Consensus Estimate. The modest advance in revenues was the result of a 6% increase in AmerisourceBergen Specialty Group’s revenue. The revenue increase for the AmerisourceBergen Specialty Group segment was driven by growth in third party logistics and vaccine and physician office distribution business. The robust performance of AmerisourceBergen Drug Corporation’s institutional segment was offset by the loss of a significant retail customer. TheraCom, a recent acquisition, also contributed toward the quarter’s ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/30/abc-amerisourcebergen-posts-modest-second-quarter-results/99760/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CHSI) SXC Health Solutions to Buy Catalyst Health</title>
		<link>http://www.stockbloghub.com/2012/04/21/chsi-sxc-health-solutions-to-buy-catalyst-health/99404</link>
		<comments>http://www.stockbloghub.com/2012/04/21/chsi-sxc-health-solutions-to-buy-catalyst-health/99404#comments</comments>
		<pubDate>Sat, 21 Apr 2012 20:20:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[Barclays plc]]></category>
		<category><![CDATA[BCS]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[SXC Health Solutions Corporation]]></category>
		<category><![CDATA[SXCI]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=99404</guid>
		<description><![CDATA[On Wednesday, Catalyst Health Solutions Inc. (CHSI) announced that it has entered into a $4.4 billion takeover agreement with rival pharmacy benefits management (PBM) company, SXC Health Solutions Corp. (SXCI). As per the agreement, SXC Health will acquire Catalyst Health for $28 per share in cash and 0.6606 shares of SXC Health in exchange of every share of Catalyst Health. Considering the closing share price of the two companies on April 17, 2012, the agreement terms translate into a purchase price of $81.02 per share of Catalyst Health, representing a 28% premium on Catalyst’s closing price of $63.54 on April 17. Following the acquisition, the shareholders of SXC Health and Catalyst Health will own 65% and 35% of the combined company, respectively. The takeover is expected to be completed by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/21/chsi-sxc-health-solutions-to-buy-catalyst-health/99404/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) Management Churn at CVS Caremark</title>
		<link>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427</link>
		<comments>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427#comments</comments>
		<pubDate>Wed, 04 Apr 2012 16:54:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAI]]></category>
		<category><![CDATA[AirTran Holdings Inc]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=97427</guid>
		<description><![CDATA[CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit Management (PBM) business, Jon Roberts will replace Per Lofberg, the President of the PBM business. However, Robert will continue to report to Lofberg who extended his employment agreement with the company till December 2013. September onwards, Lofberg will serve as the chairman of the PBM and look after the business strategies of PBM, new business development, client relationship management and retention and will directly report to Larry Merlo, the President and CEO of CVS Caremark. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Healh Analyst Reiterates Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119</link>
		<comments>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119#comments</comments>
		<pubDate>Thu, 22 Mar 2012 16:04:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAI]]></category>
		<category><![CDATA[AirTran Holdings Inc]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=96119</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00. During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks Consensus Estimate of $1.17 and 26.3% higher than the year-ago level. Increased sales combined with 8.3% reduction in number of shares outstanding contributed to the bottom-line improvement during the quarter. Additionally, the introduction of generic Lipitor contributed $0.03 to the fourth quarter EPS. For the full year, adjusted EPS came in at $4.17, surpassing the Zacks Consensus Estimate of $4.10 and was up 17.5% year over year. In fiscal 2011, Medco’s top ten clients (based on revenues) contributed approximately 46% to net revenues. Besides, the largest client, UnitedHealth accounted for 17% of net revenues. However, in July 2011, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Company News for March 12, 2012 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2012/03/13/esrx-company-news-for-march-12-2012-corporate-summary/94789</link>
		<comments>http://www.stockbloghub.com/2012/03/13/esrx-company-news-for-march-12-2012-corporate-summary/94789#comments</comments>
		<pubDate>Tue, 13 Mar 2012 18:35:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[QSFT]]></category>
		<category><![CDATA[Quest Software Inc]]></category>
		<category><![CDATA[SBUX]]></category>
		<category><![CDATA[Starbucks Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94789</guid>
		<description><![CDATA[•    Starbucks Corporation (NASDAQ:SBUX) launched the latest espresso brewer and announced that the company will be selling single-cup coffee machines •    According to reports, the Federal Trade Commission will not obstruct the merger of Express Scripts, Inc. (NASDAQ:ESRX) and MedcoHealth Solutions Inc (NYSE:MHS).  Following this development, these stocks gained 1.7% and 1.4%, respectively •    Shares of Quest Software, Inc. (NASDAQ:QSFT) jumped 24.1% following reports that Insight Venture Partners will acquire it for around $2 billion •    Zogenix, Inc. (NASDAQ:ZGNX) released lower-than-expected 2012 revenue guidance.  Consequently, its shares slumped 18.5% EXPRESS SCRIPTS (ESRX): Free Stock Analysis Report MEDCO HLTH SOL (MHS): Free Stock Analysis Report QUEST SOFTWARE (QSFT): Free Stock Analysis Report STARBUCKS CORP (SBUX): Free Stock Analysis Report ZOGENIX INC (ZGNX): Free Stock Analysis Report View original at: Zacks Investment ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/13/esrx-company-news-for-march-12-2012-corporate-summary/94789/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Inks Deal with AARP</title>
		<link>http://www.stockbloghub.com/2012/03/07/wag-walgreen-inks-deal-with-aarp/94117</link>
		<comments>http://www.stockbloghub.com/2012/03/07/wag-walgreen-inks-deal-with-aarp/94117#comments</comments>
		<pubDate>Wed, 07 Mar 2012 17:41:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94117</guid>
		<description><![CDATA[Leading drugstore chain Walgreen (WAG) recently entered into a three-year contract with a nonprofit organization AARP, to deliver retail drugstore program benefits to its members belonging to the 50-plus age group. Although both the organizations did not disclose the financial terms of the deal, but together announced that this new deal is aimed at further enhancing their long standing relationship that was initiated in 2006. This new AARP program includes AARP membership card offers, AARP online discounts and Pharmacy benefits. Concurrently, both the companies together will also develop a new event called Walgreens Way to Well Health Tour in medically underserved areas plagued with chronic diseases. Under this event, they aim to provide medical coverage to approximately 100,000 people annually. This strategic move by Walgreen should help make up for ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/07/wag-walgreen-inks-deal-with-aarp/94117/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Remains Neutral</title>
		<link>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056</link>
		<comments>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056#comments</comments>
		<pubDate>Fri, 02 Mar 2012 14:43:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94056</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00. CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the Zacks Consensus Estimate and 12.6% higher than the year-ago quarter. For the full year, adjusted EPS rose 4.5% (5.9% excluding 2010 tax benefit) to $2.80, also matching the Zacks Consensus Estimate. CVS is gradually witnessing strong performance in the field of Pharmacy Services. After a sluggish phase, the company has exhibited improved performance in this segment for the fourth consecutive quarter and has started off the 2012 selling season on a positive note. With 90% of the contract renewals scheduled for 2012 already complete at the end of fiscal 2011, CVS’s retention rate was as high ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims</title>
		<link>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162</link>
		<comments>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162#comments</comments>
		<pubDate>Fri, 13 Jan 2012 21:05:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=90162</guid>
		<description><![CDATA[Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain Medicare Part D prescription drugs at CVS Caremark and Walgreen (WAG)  pharmacies. The FTC alleged that from 2007 through November 2008, CVS Caremark’s subsidiary RxAmerica posted wrong prices on its website for prescription drugs including medications to treat epilepsy and symptoms of breast cancer. It also provided incorrect prices for posting to Plan Finder and third-party websites. The cases were extremely misleading for several seniors and disabled customers as the posted prices were 10 times below the actual prices of the drugs. This fake interpretation encouraged patients to opt for RxAmerica’s plans, which later pushed them into the &#8220;doughnut hole” ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreens 2012 First Quarter Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426</link>
		<comments>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426#comments</comments>
		<pubDate>Mon, 09 Jan 2012 16:55:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89426</guid>
		<description><![CDATA[Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period. Previous Quarter Highlights Walgreen reported first quarter 2012 EPS of 63 cents, a penny higher than the year-ago quarter earnings but missed the Zacks Consensus Estimate of 67 cents. The result includes a negative impact of 1 cent per share related to the delay in the cough/cold and flu season, 1 cent in comparable pharmacy sales related to the non-renewal of the Express Script (ESRX) contract and 1 cent in related expenses. Revenues rose 4.7% year over year to $18.2 billion and were in line with the Zacks Consensus Estimate. Comparable store sales (those open for more than a year) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld</title>
		<link>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047</link>
		<comments>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047#comments</comments>
		<pubDate>Mon, 09 Jan 2012 16:44:49 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Business Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AINV]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Apollo Investment Corporation]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Capstead Mortgage Corporation]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FAST]]></category>
		<category><![CDATA[Fastenal Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[ISIS]]></category>
		<category><![CDATA[Isis Pharmaceuticals Inc]]></category>
		<category><![CDATA[JOE]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[Northrop Grumman Corporation]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[The St. Joe Company]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89047</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards. They’re terrific students, work hard and always bring home good grades. However, it’s always a little nerve-wracking to tabulate my own report card based on my market calls at the end of the year. The market isn’t nearly as forgiving as a second grade teacher. But nevertheless, it’s an important exercise to see what I got right and what I got wrong… what I may have been a little “early” on. So here goes: In my January 14 column, I talked about the rising trend of healthcare information technology and said two of my favorite stocks in the space were AthenaHealth (Nasdaq: ATHN) and McKesson (NYSE: MCK). ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Walgreen Braves Express Scripts Loss</title>
		<link>http://www.stockbloghub.com/2012/01/03/esrx-walgreen-braves-express-scripts-loss/89521</link>
		<comments>http://www.stockbloghub.com/2012/01/03/esrx-walgreen-braves-express-scripts-loss/89521#comments</comments>
		<pubDate>Tue, 03 Jan 2012 19:16:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89521</guid>
		<description><![CDATA[The six-month dispute with Express Scripts (ESRX) took its toll on Walgreen’s (WAG) recently released first quarter fiscal 2012 results. The company’s bottom-line was impacted by 2 cents per share from the loss of pharmacy sales and expenses associated with the dispute. If a contract renewal is not finalized, effective January 1, 2012, Walgreen’s 7,800 pharmacies will not be a part of Express Scripts’ pharmacy provider network. The contract accounted for $5.3 billion of sales in fiscal 2011 as Express Scripts processed 88 million prescriptions filled by Walgreens. In the recently concluded quarter the pharmacy benefit manager processed as much as 26 million prescriptions from Walgreen. The wrangle would undoubtedly have an adverse impact on Walgreen’s sales, earnings and cash flow, going by the company’s recently filed 10Q. However, the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/03/esrx-walgreen-braves-express-scripts-loss/89521/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Plans to Offset Express Scripts Loss</title>
		<link>http://www.stockbloghub.com/2012/01/03/wag-walgreen-plans-to-offset-express-scripts-loss/89549</link>
		<comments>http://www.stockbloghub.com/2012/01/03/wag-walgreen-plans-to-offset-express-scripts-loss/89549#comments</comments>
		<pubDate>Tue, 03 Jan 2012 19:05:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89549</guid>
		<description><![CDATA[Walgreen (WAG) is commencing the New Year with efforts aimed at minimizing the impact of the non-renewal of the Express Scripts (ESRX) contract, which has just lapsed. With the intention of retaining Express Scripts’ clients, Walgreen recently came up with its comprehensive Patient Transition Plan, which will help smoothe the transition of existing members of the Express Scripts pharmacy network to another community pharmacy. Under this plan, Walgreen is providing several discounts to the members of Walgreen Prescriptions Savings Club, which facilitates savings on over 8,000 brand names and all generic drugs. The six-month dispute regarding the Express Scripts contract took its toll on Walgreen’s first quarter 2012 results. The company’s bottom-line was impacted by 2 cents per share from the loss of pharmacy sales and expenses associated with the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/03/wag-walgreen-plans-to-offset-express-scripts-loss/89549/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation to Attend Healthcare Conference</title>
		<link>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481</link>
		<comments>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481#comments</comments>
		<pubDate>Fri, 30 Dec 2011 18:17:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89481</guid>
		<description><![CDATA[The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will be represented by its president and CEO, Mr. Larry Merlo, at the conference. Currently, CVS Caremark is ranked among the top three pharmacy benefit managers (PBM) in the US. The other big players in this chart are Express Scripts (ESRX) and Medco Health Solutions (MHS). Together these three companies control roughly 50% of the market by covering approximately 240 million prescription drug consumers annually. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan sponsors, CVS Caremark holds a leading ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld</title>
		<link>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979</link>
		<comments>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979#comments</comments>
		<pubDate>Wed, 21 Dec 2011 17:42:14 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Business Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AINV]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Apollo Investment Corporation]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Capstead Mortgage Corporation]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FAST]]></category>
		<category><![CDATA[Fastenal Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[ISIS]]></category>
		<category><![CDATA[Isis Pharmaceuticals Inc]]></category>
		<category><![CDATA[JOE]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[Northrop Grumman Corporation]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[The St. Joe Company]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88979</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards. They’re terrific students, work hard and always bring home good grades. However, it’s always a little nerve-wracking to tabulate my own report card based on my market calls at the end of the year. The market isn’t nearly as forgiving as a second grade teacher. But nevertheless, it’s an important exercise to see what I got right and what I got wrong… what I may have been a little “early” on. So here goes: In my January 14 column, I talked about the rising trend of healthcare information technology and said two of my favorite stocks in the space were AthenaHealth (Nasdaq: ATHN) and McKesson (NYSE: MCK). ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark  Launches New Pharmacy Advisor Program</title>
		<link>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901</link>
		<comments>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901#comments</comments>
		<pubDate>Mon, 14 Nov 2011 18:00:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86901</guid>
		<description><![CDATA[CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness. The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication adherence for persistent illnesses such as high blood pressure, high cholesterol, coronary artery disease (CAD) and congestive heart failure (CHF). It has been noted that high blood pressure single-handedly affects one out of three adults, with the health care system costing roughly $76 billion annually. This program is based on the research done by the company along with Harvard University, Brigham and Women&#8217;s Hospital. The research, published in a healthcare journal in January, found that proper medication adherence can save nearly $4,000 hypertension patients, $1,200 high cholesterol patients and $8,000 CHF patients annually. We are encouraged by the improved performance of CVS ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/11/12/mhs-medco-analyst-maintains-shares-at-neutral-2/86959</link>
		<comments>http://www.stockbloghub.com/2011/11/12/mhs-medco-analyst-maintains-shares-at-neutral-2/86959#comments</comments>
		<pubDate>Sat, 12 Nov 2011 21:46:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86959</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $56.00. During the third quarter of fiscal 2011, Medco reported adjusted EPS of $1.07, beating the Zacks Consensus Estimate by 2 cents and 12.6% higher than the year-ago quarter level. Revenues increased 4.1% year over year to $17.0 billion in the quarter, in line with the Zacks Consensus Estimate. The increase in revenue was primarily driven by contributions from significant client wins coupled with higher prices charged for branded drugs, partially offset by higher volumes of lower-priced generic drugs. In fiscal 2010, Medco’s top ten clients (based on revenues) contributed approximately 47% to net revenues. Its largest client, UnitedHealth (UNH) accounted for 17% of net revenues. However, in July 2011, Medco failed to renew its ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/12/mhs-medco-analyst-maintains-shares-at-neutral-2/86959/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Posts a Strong Quarter</title>
		<link>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465</link>
		<comments>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465#comments</comments>
		<pubDate>Sun, 06 Nov 2011 20:15:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86465</guid>
		<description><![CDATA[CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks Consensus Estimate of 67 cents and 9.3% higher than the year-ago quarter adjusted EPS. Net revenue increased 12.5% year over year to $26.7 billion, almost in line with the Zacks Consensus Estimate. The Pharmacy Services segment posted a robust 25.8% increase in revenues to $14.8 billion during the reported quarter. The significant growth was primarily on the back of the long-term contract with Aetna (AET) as well as the acquisition of the Medicare Part D business of Universal American Corp. (UAM). These contracts, combined with an increase in covered lives in the company’s existing Medicare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Quarterly Report Beats by a Penny</title>
		<link>http://www.stockbloghub.com/2011/10/26/esrx-express-scripts-quarterly-report-beats-by-a-penny/85930</link>
		<comments>http://www.stockbloghub.com/2011/10/26/esrx-express-scripts-quarterly-report-beats-by-a-penny/85930#comments</comments>
		<pubDate>Wed, 26 Oct 2011 16:18:31 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85930</guid>
		<description><![CDATA[Express Scripts Inc.’s (ESRX) third quarter 2011 earnings of 79 cents per share (excluding special items) were a penny above the Zacks Consensus Estimate and 22% above the year-ago adjusted earnings of 65 cents per share. The jump in earnings is attributable to lower selling, general and administrative expenses and a lower share count compared with the year-ago quarter. Quarterly Details Third quarter revenues of $11.6 billion surpassed the Zacks Consensus Estimate of $11.4 billion and the year ago revenues of $11.3 billion. Adjusted gross profit for the quarter improved 7% to $864.3 million, and adjusted selling, general and administrative expenses decreased 6.2% to $200.3 million. Total adjusted claims at Express Scripts for the reported quarter came in at 160.5 million against 162.5 million in the third quarter of 2010. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/26/esrx-express-scripts-quarterly-report-beats-by-a-penny/85930/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions and United Drug Terminate Joint Venture</title>
		<link>http://www.stockbloghub.com/2011/10/20/mhs-medco-health-solutions-and-united-drug-terminate-joint-venture/85401</link>
		<comments>http://www.stockbloghub.com/2011/10/20/mhs-medco-health-solutions-and-united-drug-terminate-joint-venture/85401#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:52:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85401</guid>
		<description><![CDATA[Following the termination of the pan-European joint venture between Medco Health Solutions (MHS) and Germany-based Celesio AG, Dublin-based United Drug Plc recently decided to exit from its UK homecare partnership with Medco. As per the terms of the deal, Medco will own 100% interest in this project following the acquisition of United Drug&#8217;s 50% stake. The transaction is expected to be completed by November, 2011. However, the financial and other terms of the termination agreement remain disclosed. The joint venture, which came into existence in 2009, focused on the pharmacy homecare market in UK by providing a high level of service to patients with chronic and complex conditions and supporting the National Health Service (NHS) initiatives. We expect this move to be a hindrance for Medco in achieving its goal of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/20/mhs-medco-health-solutions-and-united-drug-terminate-joint-venture/85401/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Posts Encouraging Quarter</title>
		<link>http://www.stockbloghub.com/2011/10/07/wag-walgreen-posts-encouraging-quarter/84159</link>
		<comments>http://www.stockbloghub.com/2011/10/07/wag-walgreen-posts-encouraging-quarter/84159#comments</comments>
		<pubDate>Fri, 07 Oct 2011 16:26:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84159</guid>
		<description><![CDATA[Walgreen (WAG) reported adjusted earnings of 57 cents per share in the fourth quarter of fiscal 2011, beating the Zacks Consensus Estimate of 55 cents and were 38.3% higher than the year-ago quarter. Results for the quarter excluded an after-tax gain of 30 cents per share associated with the company’s sale of pharmacy benefits management (PBM) business, Walgreens Health Initiatives, to Catalyst Health Solutions (CHSI). The result includes negative impact of 2 cents per share from Walgreen’s acquisition of drugstore.com and restructuring and restructuring-related costs of a penny per share associated with the company’s Rewiring for Growth initiative. The year-ago quarter included negative impact of 4 cents per share from costs associated with the Duane Reade acquisition and 1 cent towards costs associated with Rewiring for Growth. For fiscal 2011, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/07/wag-walgreen-posts-encouraging-quarter/84159/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AAPL) Company News for September 28, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/10/03/aapl-company-news-for-september-28-2011-corporate-summary/84202</link>
		<comments>http://www.stockbloghub.com/2011/10/03/aapl-company-news-for-september-28-2011-corporate-summary/84202#comments</comments>
		<pubDate>Mon, 03 Oct 2011 19:20:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Aruba Networks Inc.]]></category>
		<category><![CDATA[ARUN]]></category>
		<category><![CDATA[BG]]></category>
		<category><![CDATA[Bunge Limited]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Flotek Industries Inc]]></category>
		<category><![CDATA[ftk]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>
		<category><![CDATA[Motorola Solutions]]></category>
		<category><![CDATA[MSI]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84202</guid>
		<description><![CDATA[•    Rumors did the rounds that billionaire investor Carl Icahn might purchase a stake in Research In Motion Limited (NASDAQ:RIMM) •    According to reports, Apple Inc. (NASDAQ:AAPL) is expected to launch its latest iPhone on next Tuesday •    Walgreen Co. (NYSE:WAG) was one of the heaviest losers in the S&#38;P 500 after it said that talks with Express Scripts Inc. (NASDAQ:ESRX) to renew a contract for providing prescriptions to the latter’s customers had failed •    U.S. regulatory authorities are investigating Motorola Solutions, Inc. (NYSE:MSI) to ascertain whether it paid bribes to gain business in Europe •    Flotek Industries Inc. (NYSE:FTK) said its revenues increased from $23 million in July to $25 million in August •    Jefferies initiated coverage on Aruba Networks, Inc. (NASDAQ:ARUN) with a “Hold” rating •    Citigroup, Inc. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/03/aapl-company-news-for-september-28-2011-corporate-summary/84202/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen in Elite League</title>
		<link>http://www.stockbloghub.com/2011/09/20/wag-walgreen-in-elite-league/83351</link>
		<comments>http://www.stockbloghub.com/2011/09/20/wag-walgreen-in-elite-league/83351#comments</comments>
		<pubDate>Tue, 20 Sep 2011 20:05:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health Inc.]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83351</guid>
		<description><![CDATA[Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 Information Week 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. The company considers both the achievements as huge recognition for its innovative technology in healthcare industry given the company secured a place in the top 30 list (in 2010 it was ranked 153 and secured the 3rd position among retail and general merchandising). Walgreen’s IT division is presently developing Walgreens 2.0, which will likely enhance its technology infrastructure across multiple platforms, including its network of more than 7,700 stores. Walgreen has been impacted over the past few quarters by high unemployment levels and lower discretionary spending. Moreover, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/20/wag-walgreen-in-elite-league/83351/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HWAY) Gallup-Healthways Report Well-Being</title>
		<link>http://www.stockbloghub.com/2011/09/20/hway-gallup-healthways-report-well-being/83153</link>
		<comments>http://www.stockbloghub.com/2011/09/20/hway-gallup-healthways-report-well-being/83153#comments</comments>
		<pubDate>Tue, 20 Sep 2011 19:18:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Healthways Inc]]></category>
		<category><![CDATA[HWAY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83153</guid>
		<description><![CDATA[Healthways (HWAY), the well-being enhancement company, and statistical research services provider Gallup recently announced the results of the monthly Gallup-Healthways Well-Being Index (“WBI”) for August 2011. The overarching WBI measure remained on the higher side at 66.1. The results in August marked for the first time that obesity scores, on a year-over-year basis, have dropped since the metric was introduced in 2008. The obesity measurement stood at 25.9% in August, thereby demonstrating a gradual decline in national obesity with the passage of 2011. Among the WBI sub-components, the Work Environment Index, which has not surpassed 49 since September 2009, continued to languish at 47.1. This was its third-lowest performance since the launch of the WBI. The Life Evaluation Index declined to 47.6 in the reported month, its worst performance since ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/20/hway-gallup-healthways-report-well-being/83153/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Ranked as Technology Innovator</title>
		<link>http://www.stockbloghub.com/2011/09/15/wag-walgreen-ranked-as-technology-innovator/83270</link>
		<comments>http://www.stockbloghub.com/2011/09/15/wag-walgreen-ranked-as-technology-innovator/83270#comments</comments>
		<pubDate>Thu, 15 Sep 2011 18:08:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health Inc.]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83270</guid>
		<description><![CDATA[Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 InformationWeek 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. The company considers both the achievements as huge recognition for its innovative technology in healthcare industry given the company secured a place in the top 30 list (in 2010 it was ranked 153 and secured the 3rd position among retail and general merchandising). Walgreen’s IT division is presently developing Walgreens 2.0, which will likely enhance its technology infrastructure across multiple platforms, including its network of more than 7,700 stores. Walgreen has been impacted over the past few quarters by high unemployment levels and lower discretionary spending. Moreover, the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/15/wag-walgreen-ranked-as-technology-innovator/83270/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Joins U.S. Cardiac Program</title>
		<link>http://www.stockbloghub.com/2011/09/14/wag-walgreen-joins-u-s-cardiac-program/83168</link>
		<comments>http://www.stockbloghub.com/2011/09/14/wag-walgreen-joins-u-s-cardiac-program/83168#comments</comments>
		<pubDate>Wed, 14 Sep 2011 16:32:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Harte-Hanks Inc.]]></category>
		<category><![CDATA[HHS]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83168</guid>
		<description><![CDATA[Walgreen (WAG), the US Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) have teamed up in a campaign called Million Hearts Initiative in order to prevent 1 million heart attacks and strokes over 5 years. The consortium that claims heart disease and stroke to be the first and third major causes of death, aims at a coordinated approach to promote the quality of treatment and reduce the associated risk factors. In order to support the campaign, Walgreen decides to involve over 26,000 of its pharmacists or Take Care Health providers who will offer free blood pressure testing and consultation. Walgreen also plans to promote diabetes health testing in November and heart health in February ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/14/wag-walgreen-joins-u-s-cardiac-program/83168/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FTC) Medco Health Solutions and Express Script Asked for More Information from Federal Trade Commission</title>
		<link>http://www.stockbloghub.com/2011/09/12/ftc-medco-health-solutions-and-express-script-asked-for-more-information-from-federal-trade-commission/82626</link>
		<comments>http://www.stockbloghub.com/2011/09/12/ftc-medco-health-solutions-and-express-script-asked-for-more-information-from-federal-trade-commission/82626#comments</comments>
		<pubDate>Mon, 12 Sep 2011 17:26:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Exchange Traded Fund]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82626</guid>
		<description><![CDATA[Recently, Federal Trade Commission (FTC) requested both Medco Health Solutions (MHS) and Express Script (ESRX) to submit additional information regarding the pending acquisition deal. Under the current circumstances, the completion of the proposed acquisition can get postponed by approximately 30 days. Despite the uncertainty regarding the delay, Medco anticipates to close the deal by the first half of 2012. However, the deal is also subject to approval of the stockholders of both Express Scripts and Medco. Earlier, in July 2011, Medco announced that it will be acquired by Express Scripts for $29.1 billion in cash and stock. As per the terms of the agreement, each shareholder of Medco will receive $28.80 in cash and 0.81 shares of Express Scripts, representing a total value of $71.36 per Medco share. With the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/12/ftc-medco-health-solutions-and-express-script-asked-for-more-information-from-federal-trade-commission/82626/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891</link>
		<comments>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891#comments</comments>
		<pubDate>Sun, 11 Sep 2011 16:43:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82891</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00. CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing the Zacks Consensus Estimate by a penny but meeting the year-ago quarter’s adjusted EPS. After a period of sluggish performance, CVS’ Pharmacy Benefit Management (PBM) segment grew for the second consecutive quarter. During the quarter, this segment recorded a robust 23.2% year-over-year increase in revenues to reach $14.6 billion. The year-over upside was primarily driven by a 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers as well as the new acquisition of the Medicare Part D business of Universal American Corp (UAM). The company is also confident of achieving further growth in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CHSI) Catalyst Health Solutions Performs Well</title>
		<link>http://www.stockbloghub.com/2011/08/05/chsi-catalyst-health-solutions-performs-well/80594</link>
		<comments>http://www.stockbloghub.com/2011/08/05/chsi-catalyst-health-solutions-performs-well/80594#comments</comments>
		<pubDate>Fri, 05 Aug 2011 17:43:04 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=80594</guid>
		<description><![CDATA[Catalyst Health Solutions Inc. (CHSI) reported second-quarter operating earnings of 53 cents per share, at par with the Zacks Consensus Estimate. The results compare favorably with earnings of 46 cents in the prior-year quarter. Catalyst Health’s operating earnings in the reported quarter excludes the impact of non-recurring items such as costs related to Walgreens Health Initiatives Inc. (&#8220;WHI&#8221;) acquisition and amortization of FutureScripts related intangible assets. Including amortization adjustments, net income reported by Catalyst Health was $12.3 million or 25 cents per share, substantially down from $19.5 million or 44 cents in the prior-year quarter. The year-over-year increase was attributable to a strong marketing strategy that supported the top-line and improved operational performance. Besides, the acquisition of WHI was significant and provided meaningful growth in earnings. However, it led to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/05/chsi-catalyst-health-solutions-performs-well/80594/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Revenue Rises &#8211; Earnings Report In Line</title>
		<link>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677</link>
		<comments>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677#comments</comments>
		<pubDate>Thu, 04 Aug 2011 16:58:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ASR]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Grupo Aeroportuario Del Sureste SA de CV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79677</guid>
		<description><![CDATA[Express Scripts Inc.’s (ESRX) second quarter 2011 earnings of 71 cents per share (excluding special items) were in line with the Zacks Consensus Estimate but were well above the year-ago adjusted earnings of 60 cents per share. The jump in earnings is attributable to reduced selling, general and administrative expenses and a lower share count as compared with the year-ago quarter. Quarterly Details Second quarter revenues of $11.36 billion surpassed the Zacks Consensus Estimate of $11.32 billion and the year ago revenues of $11.29 billion. Adjusted gross profit for the quarter improved 4.5% to $812.6 million, and adjusted selling, general and administrative expenses decreased 8.5% to $194.6 million. Total claims at Express Scripts for the reported quarter came in at 161.4 million against 164.5 million in the second quarter of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Express Scripts to Buy Medco Health Solutions</title>
		<link>http://www.stockbloghub.com/2011/08/04/mhs-express-scripts-to-buy-medco-health-solutions/79676</link>
		<comments>http://www.stockbloghub.com/2011/08/04/mhs-express-scripts-to-buy-medco-health-solutions/79676#comments</comments>
		<pubDate>Thu, 04 Aug 2011 16:57:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79676</guid>
		<description><![CDATA[Following the release of its second quarter of fiscal 2011 earnings, Medco Health Solutions (MHS) announced that it will be acquired by Express Scripts (ESRX) for $29.1 billion in cash and stock. As per the terms of the agreement, each shareholder of Medco will receive $28.80 in cash and 0.81 shares of Express Scripts, representing a total value of $71.36 per Medco share. This represents a premium of 28% over Medco&#8217;s closing share price on July 20, 2011. Following completion of the deal (expected in first half of 2012), Express Scripts Holding Company will be formed wherein 59% of the holding would lie with the shareholders of Express Scripts. In continuation of its series of contract losses over the last few months, Medco’s long-time negotiation with its biggest client UnitedHealth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/04/mhs-express-scripts-to-buy-medco-health-solutions/79676/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BT) Company News for July 22, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary-2/79705</link>
		<comments>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary-2/79705#comments</comments>
		<pubDate>Fri, 22 Jul 2011 21:37:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Foreign]]></category>
		<category><![CDATA[BB & T Corporation]]></category>
		<category><![CDATA[BBT]]></category>
		<category><![CDATA[BT]]></category>
		<category><![CDATA[BT Group plc]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[RHI]]></category>
		<category><![CDATA[Robert Half International Inc.]]></category>
		<category><![CDATA[SFN]]></category>
		<category><![CDATA[Spherion Corporation]]></category>
		<category><![CDATA[WCC]]></category>
		<category><![CDATA[WESCO International Inc.]]></category>
		<category><![CDATA[WNS]]></category>
		<category><![CDATA[WNS (Holdings) Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79705</guid>
		<description><![CDATA[•    BB&#38;T Corp. (NYSE:BBT) reported Q2 EPS of $0.44, slightly above the Zacks Consensus Estimate of $0.42 per share. Revenues rose 7% year-over-year to $2.18 billion, beating the Zacks Consensus Estimate of $2.148 billion •    WESCO International, Inc. (NYSE:WCC) reported Q2 EPS of $1.00, surpassing the Zacks Consensus Estimate of $0.92 per share. Revenues for the quarter rose 21.1% year-over-year to $1.52 billion •    WNS Limited (NYSE:WNS) reported Q1 EPS of $0.22, beating the Zacks Consensus Estimate of $0.15 per share. Revenues for the quarter rose 9.5% year-over-year to $97.8 million, ahead of the Zacks Consensus Estimate of $94.0 million •    Express Scripts, Inc. (NASDAQ:ESRX) reported Q2 EPS of $0.71, in line with the Zacks Consensus Estimate. However, revenues for the quarter rose 0.6% year-over-year to $11.36 billion, higher than ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary-2/79705/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BT) Company News for July 22, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary/79658</link>
		<comments>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary/79658#comments</comments>
		<pubDate>Fri, 22 Jul 2011 16:49:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Foreign]]></category>
		<category><![CDATA[BB & T Corporation]]></category>
		<category><![CDATA[BBT]]></category>
		<category><![CDATA[BT]]></category>
		<category><![CDATA[BT Group plc]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[RHI]]></category>
		<category><![CDATA[Robert Half International Inc.]]></category>
		<category><![CDATA[SFN]]></category>
		<category><![CDATA[Spherion Corporation]]></category>
		<category><![CDATA[WCC]]></category>
		<category><![CDATA[WESCO International Inc.]]></category>
		<category><![CDATA[WNS]]></category>
		<category><![CDATA[WNS (Holdings) Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79658</guid>
		<description><![CDATA[•    BB&#38;T Corp. (NYSE:BBT) reported Q2 EPS of $0.44, slightly above the Zacks Consensus Estimate of $0.42 per share. Revenues rose 7% year-over-year to $2.18 billion, beating the Zacks Consensus Estimate of $2.148 billion •    WESCO International, Inc. (NYSE:WCC) reported Q2 EPS of $1.00, surpassing the Zacks Consensus Estimate of $0.92 per share. Revenues for the quarter rose 21.1% year-over-year to $1.52 billion •    WNS Limited (NYSE:WNS) reported Q1 EPS of $0.22, beating the Zacks Consensus Estimate of $0.15 per share. Revenues for the quarter rose 9.5% year-over-year to $97.8 million, ahead of the Zacks Consensus Estimate of $94.0 million •    Express Scripts, Inc. (NASDAQ:ESRX) reported Q2 EPS of $0.71, in line with the Zacks Consensus Estimate. However, revenues for the quarter rose 0.6% year-over-year to $11.36 billion, higher than ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/22/bt-company-news-for-july-22-2011-corporate-summary/79658/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen&#8217;s June Sales Swell</title>
		<link>http://www.stockbloghub.com/2011/07/08/wag-walgreens-june-sales-swell/78633</link>
		<comments>http://www.stockbloghub.com/2011/07/08/wag-walgreens-june-sales-swell/78633#comments</comments>
		<pubDate>Fri, 08 Jul 2011 21:01:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78633</guid>
		<description><![CDATA[Leading retail pharmacy chain, Walgreen (WAG) reported sales of $6.04 billion in June, up 6.8% from the year-ago period. Total front-end sales increased 6.4% while comparable store’s front-end sales increased 4.7%. Prescriptions filled at comparable stores went up by 5%, which was impacted by 0.3 percentage points due to calendar day shifts. Pharmacy sales that accounted for 65.6% of total sales increased 6.2% with 4.9% higher comparable pharmacy sales. Comparable pharmacy sales were negatively impacted by 2.1 percentage points due to generic drug introductions over the past 12 months. At the end of June, Walgreens operated 8,184 locations in all 50 states, the District of Columbia, Puerto Rico and Guam. Tagging along with Core Performance, Walgreen’s Take Care Health Systems will offer Core Performance wellness services to its corporate clients. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/08/wag-walgreens-june-sales-swell/78633/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Expands in Chicago</title>
		<link>http://www.stockbloghub.com/2011/06/30/wag-walgreen-expands-in-chicago/78025</link>
		<comments>http://www.stockbloghub.com/2011/06/30/wag-walgreen-expands-in-chicago/78025#comments</comments>
		<pubDate>Thu, 30 Jun 2011 21:15:22 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78025</guid>
		<description><![CDATA[Leading retail pharmacy chain Walgreen Co. (WAG) has recently launched a project called ‘Chicago Hometown Investment Initiative’, which is expected to offer approximately 600 new job opportunities in the city over the next couple of years and increase fourfold the number of food oasis stores of Walgreen (from 11 to nearly 50). The company believes that the expansion of downtown office space for E-commerce, information technology and related areas will provide half of the jobs committed. The remaining 300 jobs will be created through new store openings and remodeling of some of 142 Walgreen drugstores in Chicago. With the acquisition of drugstore.com on June 3, 2011, Walgreen has started planning for a downtown office space expansion in Chicago with the intention of establishing itself as a strong multi-channel retailer of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/30/wag-walgreen-expands-in-chicago/78025/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreens Debuts Web Pickup in Chicago</title>
		<link>http://www.stockbloghub.com/2011/06/29/wag-walgreens-debuts-web-pickup-in-chicago/77715</link>
		<comments>http://www.stockbloghub.com/2011/06/29/wag-walgreens-debuts-web-pickup-in-chicago/77715#comments</comments>
		<pubDate>Wed, 29 Jun 2011 15:36:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77715</guid>
		<description><![CDATA[Leading retail pharmacy chain Walgreen Co. (WAG) has recently undertaken an innovative initiative to enhance its sales and distribution by launching Web Pickup service across Chicago. The program will enable customers to shop online at Walgreens.com and pick up the placed orders at the Walgreen stores within an hour. The non-prescription items will be available online through the service. The service is already available at 27 Walgreen stores in California. However, the company has chosen Chicago for the first full market roll out of the Web Pickup program. Presently, Web Pickup is available at 300 locations in the Chicago metropolitan area. The full market roll out across 480 locations is expected to be completed by August, 2011. Walgreen offers pharmacy benefit management (PBM), mail service, home care and specialty pharmacy ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/29/wag-walgreens-debuts-web-pickup-in-chicago/77715/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Optimism in the Market</title>
		<link>http://www.stockbloghub.com/2011/06/22/wag-optimism-in-the-market/76921</link>
		<comments>http://www.stockbloghub.com/2011/06/22/wag-optimism-in-the-market/76921#comments</comments>
		<pubDate>Wed, 22 Jun 2011 17:09:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Economic Crises]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76921</guid>
		<description><![CDATA[The backdrop for today&#8217;s market action is the last Fed meeting of the QE2 era and a critical vote in the Greek parliament later today. Stocks appear to be discounting a happier outcome in the ongoing Greek Drama. We also saw relatively more momentum in some of the cyclical sectors on Monday. This may be reflective of a less worried view of the growth question that has been weighing on stocks over the last few weeks. More likely it is reflective of a tentative bounceback from over-sold conditions in the hope of a second-half recovery. In any case, it is difficult to read much into the market&#8217;s modest gains over the last few days, particularly in the absence of any positive economic data. In Greece, the reshuffled cabinet of Prime ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/wag-optimism-in-the-market/76921/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Walgreen&#8217;s Terminates Agreement With Express Scripts</title>
		<link>http://www.stockbloghub.com/2011/06/22/esrx-walgreens-terminates-agreement-with-express-scripts/77053</link>
		<comments>http://www.stockbloghub.com/2011/06/22/esrx-walgreens-terminates-agreement-with-express-scripts/77053#comments</comments>
		<pubDate>Wed, 22 Jun 2011 17:03:53 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77053</guid>
		<description><![CDATA[With just half a year left for the termination of the agreement, Express Scripts Inc. (ESRX) recently announced that Walgreen Co. (WAG) is not renewing its agreement with Express Scripts. In a move that has shocked Express Scripts, Walgreen will not be a part of Express Scripts’ pharmacy provider network, effective January 1, 2012. The company believes that Walgreen’s current rates are not competitive as compared with its peers. In the coming few years the cost of non-specialty branded medications is forecasted to increase about 10% annually and cost of branded specialty medications is expected to jump more than 14% per year. If Walgreen does not agree to adjust its rates, the clients and patients will be burdened by the branded price inflation. Moreover, more than $60 billion worth of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/esrx-walgreens-terminates-agreement-with-express-scripts/77053/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HWAY) Healthways Announces Insurance Deal for Wisconsin Fitness Drive</title>
		<link>http://www.stockbloghub.com/2011/06/16/hway-healthways-announces-insurance-deal-for-wisconsin-fitness-drive/76488</link>
		<comments>http://www.stockbloghub.com/2011/06/16/hway-healthways-announces-insurance-deal-for-wisconsin-fitness-drive/76488#comments</comments>
		<pubDate>Thu, 16 Jun 2011 14:24:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Healthways Inc]]></category>
		<category><![CDATA[HWAY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76488</guid>
		<description><![CDATA[Healthways (HWAY), the well-being enhancement company, recently announced a new agreement with WPS Health Insurance (a non-profit health insurer in Wisconsin), whereby over 38,000 Wisconsin residents will gain access to the well-known SilverSneakers Fitness Program. As of the beginning of June 2011, SilverSneakers became accessible to eligible enrollees of WPS Medicare Companion, a Medicare supplemental insurance program in the state. The SilverSneakers program is America’s foremost exercise and social support program that aims at keeping senior citizens fit. Its regimen was created keeping in mind the physical constraints of older citizens and training is accordingly imparted by certified trainers. WPS will offer SilverSneakers at no extra cost to its Medicare Companion enrollees. SilverSneakers grants eligible participants access to over 11,000 wellness and fitness clinics across the nation. Many centers provide ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/16/hway-healthways-announces-insurance-deal-for-wisconsin-fitness-drive/76488/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CHSI) Catalyst Health Solutions First Quarter 2011 Earnings Soar!</title>
		<link>http://www.stockbloghub.com/2011/05/09/chsi-catalyst-health-solutions-first-quarter-2011-earnings-soar/73640</link>
		<comments>http://www.stockbloghub.com/2011/05/09/chsi-catalyst-health-solutions-first-quarter-2011-earnings-soar/73640#comments</comments>
		<pubDate>Mon, 09 May 2011 21:34:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73640</guid>
		<description><![CDATA[Catalyst Health Solutions Inc. (CHSI) reported first-quarter 2011 adjusted earnings of 52 cents per share, surpassing the Zacks Consensus Estimate of 50 cents. The results also compare favorably with earnings of 41 cents in the prior-year quarter. Catalyst Health’s adjusted earnings in the reported quarter exclude the adjustment for Walgreens Health Initiatives, Inc. (“WHI”) transaction related costs, amortization of FutureScripts related intangible assets and all other acquisition-related intangible assets. Including amortization adjustments, net income reported by Catalyst Health was $20.3 million or 45 cents per share, as against $17.4 million or 39 cents in the prior-year quarter. The year-over-year increase was attributable to a strong marketing strategy and leveraging its infrastructure and controlling overhead expenses. Besides, the strategic initiative of WHI was significant and provided meaningful growth in earnings. Quarter ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/09/chsi-catalyst-health-solutions-first-quarter-2011-earnings-soar/73640/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) WellPoint Quarterly Earnings Outshine &#8211; Company Increases Outlook</title>
		<link>http://www.stockbloghub.com/2011/05/03/wlp-wellpoint-quarterly-earnings-outshine-company-increases-outlook/72615</link>
		<comments>http://www.stockbloghub.com/2011/05/03/wlp-wellpoint-quarterly-earnings-outshine-company-increases-outlook/72615#comments</comments>
		<pubDate>Tue, 03 May 2011 19:07:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72615</guid>
		<description><![CDATA[WellPoint Inc. (WLP) reported its first-quarter income from continuing operations of $891.0 million or $2.35 per share, surpassing the Zacks Consensus Estimate of $1.87. This also compares favorably with the income of $871.9 million or earnings of $1.95 in the year-ago quarter. The improved showing was attributable to higher operating cash flows and the implementation of organizational changes in health care. Besides, the jump in medical enrollment also contributed to the increase. WellPoint’s income from continuing operations excludes net investment gains of $35.6 million after-tax, or 9 cents per share in the first quarter of 2011; while net operating income in the first quarter of 2010 excludes net investment gains of $18.6 million after-tax or 4 cents per share, which was partially offset by an intangible asset impairment charge of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/03/wlp-wellpoint-quarterly-earnings-outshine-company-increases-outlook/72615/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) WellPoint Provides 2011 Guidance</title>
		<link>http://www.stockbloghub.com/2011/03/04/wlp-wellpoint-provides-2011-guidance/67661</link>
		<comments>http://www.stockbloghub.com/2011/03/04/wlp-wellpoint-provides-2011-guidance/67661#comments</comments>
		<pubDate>Sat, 05 Mar 2011 00:43:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67661</guid>
		<description><![CDATA[WellPoint Inc. (WLP), at its investor conference provided its guidance for full year 2011. The company reaffirmed its expectation of delivering net income of least $6.30 per share. The Zacks Consensus Estimates for 2011 is in line with the company’s guidance. The company also expects to achieve earnings per share growth of at least 10% over a longer term. WellPoint expects operating revenue to be $59.5 million in 2011, up 3% year over year. The company also expects Medical enrollment growth in the National, State Sponsored, Senior and Federal Employee Plan businesses, partially offset by attrition in Local Group and Individual. Selling, General and Administrative (SG&#38;A) expenses are likely to decrease $400 million or 4.5%, and the SG&#38;A Expense Ratio is projected to be 14.2%, a decrease of 110 basis ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/04/wlp-wellpoint-provides-2011-guidance/67661/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SIGA) These Healthcare Stocks Are Ready to Move Next Week</title>
		<link>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553</link>
		<comments>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553#comments</comments>
		<pubDate>Fri, 07 Jan 2011 18:11:43 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[CGEN]]></category>
		<category><![CDATA[Compugen Limited]]></category>
		<category><![CDATA[DCTH]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Nektar Therapeutics]]></category>
		<category><![CDATA[NKTR]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[SIGA Technologies Inc]]></category>
		<category><![CDATA[TEVA]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Limited]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=64553</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Senior Analyst Wednesday, January 5, 2011: Issue #1421 Once again, I’ve secured my golden ticket to the most important healthcare event of the year. In the past, I’ve described the JP Morgan Healthcare Conference as the Super Bowl of the healthcare investing world. That’s no exaggeration either, as industry executives and investors jet in from all over the world to attend. And with hotels, restaurants and even the 37 Starbucks in Union Square packed with people looking for and providing information, even those without an invitation still hit San Francisco just to be near the action. It’s the place to get the latest news on drug development, research funding, and the companies that could be on the cusp of greatness. And for the past few ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLXP) Salix Pharmaceuticals Posts Narrower Third Quarter 2010 Loss</title>
		<link>http://www.stockbloghub.com/2010/11/17/slxp-salix-pharmaceuticals-posts-narrower-third-quarter-2010-loss/59433</link>
		<comments>http://www.stockbloghub.com/2010/11/17/slxp-salix-pharmaceuticals-posts-narrower-third-quarter-2010-loss/59433#comments</comments>
		<pubDate>Thu, 18 Nov 2010 05:19:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Related Products]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Salix Pharmaceuticals Limited]]></category>
		<category><![CDATA[SLXP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=59433</guid>
		<description><![CDATA[Salix Pharmaceuticals, Ltd. (SLXP) posted a loss of 5 cents per share in the third quarter of 2010, narrower than the Zacks Consensus Estimate of a loss of 15 cents and the guidance provided by the company (loss of 13 cents). Salix had reported a loss of 15 cents in the year-ago quarter. Higher revenues helped the company post a narrower loss in the reported quarter. Third quarter revenues increased 22.8% to $80.6 million, mainly due to strong Xifaxan sales. Revenues were well above the company’s guidance of $73 million and the Zacks Consensus Estimate of $76 million. Quarter in Detail Salix’ third quarter performance was driven by its key product Xifaxan, which posted sales of $65.2 million, up 53%. Prescriptions grew 65% during the third quarter. Salix reported that ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/17/slxp-salix-pharmaceuticals-posts-narrower-third-quarter-2010-loss/59433/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) WellPoint Earnings Reports Outshines &#8211; Forecast Raised</title>
		<link>http://www.stockbloghub.com/2010/11/07/wlp-wellpoint-earnings-reports-outshines-forecast-raised/57978</link>
		<comments>http://www.stockbloghub.com/2010/11/07/wlp-wellpoint-earnings-reports-outshines-forecast-raised/57978#comments</comments>
		<pubDate>Sun, 07 Nov 2010 20:26:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=57978</guid>
		<description><![CDATA[WellPoint Inc. (WLP) reported its third-quarter income from continuing operations of $701.2 million or $1.74 per share, surpassing the Zacks Consensus Estimate of $1.58. However, this compares unfavorably with the income of $850.5 million or earnings of $1.78 in the year-ago quarter. The improved showing was attributable to higher-than-expected favorable reserve development and continued strong performance in administrative expense management. WellPoint’s income from continuing operations excludes net investment gains of $37.9 million after-tax, or approximately 10 cents per share in the reported quarter, while it excludes net investment gains of $14.1 million after-tax or 3 cents per share and an impairment charge of $134.4 million after-tax, or 28 cents per share in the prior year quarter. Including these one-time items, WellPoint reported a net income of $739.1 million or $1.84 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/07/wlp-wellpoint-earnings-reports-outshines-forecast-raised/57978/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PBM) Catalyst Health Solutions Acquires FutureScripts</title>
		<link>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475</link>
		<comments>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475#comments</comments>
		<pubDate>Tue, 14 Sep 2010 20:22:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[JEF]]></category>
		<category><![CDATA[Jefferies Group Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=51475</guid>
		<description><![CDATA[Expanding its pharmacy benefit management (PBM) solutions, on Monday, Catalyst Health Solutions Inc. (CHSI) announced the purchase of all the PBM units of Independence Blue Cross (IBC) ? FutureScripts LLC and FutureScripts Secure LLC ? for an all cash transaction of $225 million. Both the entities have also received the regulatory approvals relevant for the deal. According to the terms laid, IBC has agreed to allow Catalyst Health to manage the former’s PBM service operations for a new 10-year term period. Moreover, IBC has included the future tax benefit for Catalyst Health in the deal value, based on the arrangement of the transaction. On August 4, both Catalyst Health and IBC had agreed on the terms of the deal. While Jefferies &#38; Company Inc. of Jefferies Group Inc. (JEF) acted ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) WellPoint Second Quarter 2010 Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2010/08/22/wlp-wellpoint-second-quarter-2010-earnings-scorecard/48199</link>
		<comments>http://www.stockbloghub.com/2010/08/22/wlp-wellpoint-second-quarter-2010-earnings-scorecard/48199#comments</comments>
		<pubDate>Sun, 22 Aug 2010 23:02:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Miller Industries Inc]]></category>
		<category><![CDATA[MLR]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=48199</guid>
		<description><![CDATA[Following the release of second quarter results on July 28, 2010, the majority of analysts covering WellPoint Inc. (WLP) made upward revisions to their fourth-quarter and 2010 annual estimates. However, third-quarter of 2010 and 2011 annual estimates witnessed more of a downward trend among analysts over the last 30-day period. Earnings Report Review The company performed impressively in the second quarter, beating the Zacks Consensus Estimate by 11 cents and year-ago earnings by 17 cents (excluding special items). Following the impressive first quarter results, the company raised the 2010 net income guidance and lowered its operating revenue outlook. WellPoint’s earnings in the reported quarter were $1.67 per share, excluding net investment gains of 4 cents per share. On a reported basis, the company earned $1.71 per share, against year-ago earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/22/wlp-wellpoint-second-quarter-2010-earnings-scorecard/48199/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AET) Aetna and CVS Caremark Strike Deal</title>
		<link>http://www.stockbloghub.com/2010/08/02/aet-aetna-and-cvs-caremark-strike-deal/46056</link>
		<comments>http://www.stockbloghub.com/2010/08/02/aet-aetna-and-cvs-caremark-strike-deal/46056#comments</comments>
		<pubDate>Tue, 03 Aug 2010 04:22:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=46056</guid>
		<description><![CDATA[Last week, health insurer Aetna Inc. (AET) announced that it has entered into a 12-year contract with pharmacy benefit manager (PBM) CVS Caremark (CVS). Pursuant to the agreement, Caremark will act as a PBM of Aetna’s prescription drug program for its Pharmacy Benefit Unit. In the United States, a PBM is a third-party administrator of prescription drug programs who are primarily responsible for processing and paying prescription drug claims. Caremark will take on responsibility for 9.7 million of Aetna’s members, besides being responsible for developing and maintaining the formulary, contracting with pharmacies, and negotiating discounts and rebates with drug manufacturers. The contract will help Aetna lower medical costs for its members on the back of price discounts from retail pharmacies, rebates from pharmaceutical manufacturers, and the efficiencies of mail-service pharmacies. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/02/aet-aetna-and-cvs-caremark-strike-deal/46056/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) WellPoint Earnings Beat &#8211; Raises Outlook</title>
		<link>http://www.stockbloghub.com/2010/07/28/wlp-wellpoint-earnings-beat-raises-outlook/45097</link>
		<comments>http://www.stockbloghub.com/2010/07/28/wlp-wellpoint-earnings-beat-raises-outlook/45097#comments</comments>
		<pubDate>Wed, 28 Jul 2010 18:56:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[DCP]]></category>
		<category><![CDATA[DynCorp International Inc]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=45097</guid>
		<description><![CDATA[On July 28, 2010, WellPoint Inc. (WLP) reported its second-quarter income from continuing operations of $702.8 million or $1.67 per share, surpassing the Zacks Consensus Estimate of $1.56. This also compares favorably with the income of $731.5 million or earnings of $1.50 in the year-ago quarter. The improved showing was attributable to higher-than-expected favorable reserve development and continued strong performance in capital management. WellPoint’s income from continuing operations excludes net investment gains of $19.6 million after-tax, or $0.04 per share in the reported quarter and net investment losses of $38.0 million after-tax or $0.07 per share in the prior-year quarter. Including these one-time items, WellPoint reported a net income of $722.4 million or $1.71 per share as opposed to $693.5 million or $1.43 per share. Behind the Headlines Total operating ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/28/wlp-wellpoint-earnings-beat-raises-outlook/45097/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Tops Expectations and Guides Up</title>
		<link>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029</link>
		<comments>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:16:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29029</guid>
		<description><![CDATA[Express Scripts Inc. (ESRX) announced better-than-expected results with fourth-quarter earnings of 97 cents per share, 7 cents above the Zacks Consensus Estimate. Earnings increased 14.1% from the year-ago period. Full year earnings were $3.58 per share, 12 cents above the Zacks Consensus Estimate and well above the year ago earnings of $3.18. Fourth quarter revenues increased a whopping 49% to $8.2 billion. Full year revenues increased 12.6% to $24.7 billion. We believe that the company benefited from new business gained through its acquisition of NextRx, the pharmacy business management (PBM) segment of WellPoint Inc. (WLP). NextRx provides PBM services to approximately 25 million Americans and manages more than 265 million adjusted prescriptions annually. We view Express Scripts’ acquisition of NextRx as a smart strategic move. The aligned business model should ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CAH) Cardinal Health Beats Expectations and Boosts Estimates</title>
		<link>http://www.stockbloghub.com/2010/01/28/cah-cardinal-health-beats-expectations-and-boosts-estimates/26312</link>
		<comments>http://www.stockbloghub.com/2010/01/28/cah-cardinal-health-beats-expectations-and-boosts-estimates/26312#comments</comments>
		<pubDate>Thu, 28 Jan 2010 20:26:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs Wholesale]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26312</guid>
		<description><![CDATA[Cardinal Health, Inc. (CAH) reported second quarter fiscal 2010 earnings per share of 57 cents, surpassing the Zacks Consensus Estimate of 46 cents and the year-ago earnings of 51 cents. Sales Total sales in the reported quarter increased 3% year over year to $24.9 billion. Growth was witnessed across all business segments. Pharmaceutical segment revenues increased 3% year over year to $22.7 billion. Growth was primarily fueled by higher sales to existing pharmaceutical distribution customers. Sales to bulk customers declined 1% year over year to $11 billion. Sales to non-bulk customers increased 7% year over year to $11.7 billion. Medical segment revenues increased 9% year over year to $2.2 billion. Growth can be primarily attributed to higher sales to existing customers. Margins Gross and operating margins remained unchanged at 3.8% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/28/cah-cardinal-health-beats-expectations-and-boosts-estimates/26312/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

